Adropin: A New Marker for Predicting Late Saphenous Vein Graft Disease after Coronary Artery Bypass Grafting | Zendy

Bora Demirçelik | Zendy; Muzaffer Çakmak | Zendy; Yunus Nazlı | Zendy; Özgül Malçok Gürel | Zendy; Nermin Akkaya | Zendy; Mustafa Çetın | Zendy; Zehra Güven Çetin | Zendy; Yusuf Selçoki | Zendy; Alparslan Kurtul | Zendy; Beyhan Eryonucu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Adropin: A New Marker for Predicting Late Saphenous Vein Graft Disease after Coronary Artery Bypass Grafting

Author(s) -

Bora Demirçelik,

Muzaffer Çakmak,

Yunus Nazlı,

Özgül Malçok Gürel,

Nermin Akkaya,

Mustafa Çetın,

Zehra Güven Çetin,

Yusuf Selçoki,

Alparslan Kurtul,

Beyhan Eryonucu

Publication year - 2014

Publication title -

clinical and investigative medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.391

H-Index - 47

eISSN - 1488-2353

pISSN - 0147-958X

DOI - 10.25011/cim.v37i5.22014

Subject(s) - medicine , occlusion , bypass grafting , cardiology , artery , vein , anastomosis , complication , surgery , coronary artery disease , pathogenesis , saphenous vein graft

Saphenous vein graft disease (SVGD), defined as an occlusion of 50% or more of the SVG excluding distal anastomotic occlusion, is an important predictor of morbidity after coronary artery bypass grafting (CABG). Late graft occlusion is a serious complication that often limits the use of the saphenous vein as a coronary bypass graft. Late graft occlusion is particularly common in old, degenerated venous grafts with advanced atherosclerotic plaques. Adropin has been implicated in the homeostatic control of metabolism. The purpose of this study was to investigate whether serum adropin levels are associated with late SVGD following CABG.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research